human glp-1 sequence Peptide of native and lixisenatide. (A) Native Peptide sequences and molecular structures

These results highlight significant heterogeneity in weight trajectories following sustained exposure to a GLP-1RA therapy and identifies factors associated with increased weight loss, likely reflecting a combination of biological, behavioral, and social factors

The study published in JAMA Psychiatry found that patients with alcohol use disorder (AUD) who were prescribed GLP-1 drugs, popularly known by their brand names Ozempic and Wegovy, had a significantly lower risk of hospitalization for alcohol-related issues.Background on Semaglutide and LiraglutideSemaglutide and liraglutide are medications b

Medication persistence, or remaining on a medication as prescribed, is crucial for meaningful obesity management outcomes.

A new Gallup poll shows 11% of adults say they are currently using one, a dramatic increase from just two years ago, when...

Discover how to optimize both strategies for sustainable weight loss without compromising nutrition

This review summarizes the existing knowledge derived from animal studies on the effects of GLP-1RAs and GLP-1RA related peptide polyagonists on NAFLD in an attempt to illuminate areas of uncertainty and provide the groundwork for future animal and clinical research in the field.